<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>865</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>10820384</PubmedId>
            <Abstract>Yersinia enterocolitica delivers a set of effector proteins [Yersinia outer proteins (Yop)] into the cytosol of target cells to modulate host cell signal transduction pathways required for the extracellular survival of the bacterium. Secretion and subsequent translocation of Yop across the eukaryotic cell membrane are achieved via a type III secretion system. About 50 - 100 amino acids of the N terminus of Yop are required for chaperone-directed secretion and translocation. In this study, it is demonstrated by immunoblot analysis of Yersinia-infected cultured epithelial cells that one ot these proteins, YopE, can serve as a molecular carrier to deliver protein fragments of the heterologous p60 antigen of Listeria monocytogenes into the cytosol of target cells. T cell activation assays revealed that the observed type III-mediated antigen translocation led to a p60 peptide-specific MHC class I-restricted antigen presentation. Efficient translocation and antigen presentation were strictly dependent on the co-localized expression of hybrid YopE-p60 proteins and the YopE-specific chaperone SycE. These results suggest that the Yersinia type III secretion system may serve as an attractive tool for antigen delivery in Yersinia-based live vaccines to induce cellular immune responses.</Abstract>
            <ArticleYear>2000</ArticleYear>
            <ArticlePages>1375-84</ArticlePages>
            <ArticleTitle>Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Rüssmann</LastName>
                    <ForeName>H</ForeName>
                </Author>
                <Author>
                    <LastName>Weissmüller</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Geginat</LastName>
                    <ForeName>G</ForeName>
                </Author>
                <Author>
                    <LastName>Igwe</LastName>
                    <ForeName>E I</ForeName>
                </Author>
                <Author>
                    <LastName>Roggenkamp</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Bubert</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Goebel</LastName>
                    <ForeName>W</ForeName>
                </Author>
                <Author>
                    <LastName>Hof</LastName>
                    <ForeName>H</ForeName>
                </Author>
                <Author>
                    <LastName>Heesemann</LastName>
                    <ForeName>J</ForeName>
                </Author>
            </Authors>
            <Affiliations>Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, Ludwig Maximilians Universität München, München, Germany. ruessman@m3401.mpk.med.uni-muenchen.de.</Affiliations>
            <ArticleChemicalList>Antigens, Bacterial;Bacterial Outer Membrane Proteins;Histocompatibility Antigens Class I;Peptides;yopE protein, Yersinia</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antigen Presentation; Antigens, Bacterial(immunology); Bacterial Outer Membrane Proteins(immunology); Bacterial Translocation; Histocompatibility Antigens Class I(immunology); Mice; Mice, Inbred BALB C; Peptides(immunology); T-Lymphocytes(immunology); Yersinia Infections(immunology); Yersinia enterocolitica(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>30</Volume>
                <Issue>5</Issue>
                <Title>European journal of immunology</Title>
                <Issn>0014-2980</Issn>
                <MedlineTa>Eur J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>p60 217-225</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KYGVSVQDI</LinearSequence>
                        <StartingPosition>217</StartingPosition>
                        <EndingPosition>225</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P21171.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>169963</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Received from author.</LocationOfData>
                <EpitopeId>34446</EpitopeId>
                <ReferenceStartingPosition>217</ReferenceStartingPosition>
                <ReferenceEndingPosition>225</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Kd restricted epitope. Also known as Protein p60 precursor and  Invasion-associated protein.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <TCellId>9523</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>169963</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1st dose of 5x10&lt;sup&gt;3&lt;/sup&gt; CFU, 2nd dose of 10^6 CFU 2 wks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>P815-Mast cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KYGVSVQDI</LinearSequence>
                                            <StartingPosition>217</StartingPosition>
                                            <EndingPosition>225</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P21171.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>169963</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Peptide specific T cell line was established by incubation with epitopic peptide  and restimulated every 3-4 wks with P815/B7 accessory cells.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10000055</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>p60 214-273</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYGVSVQDI</LinearSequence>
                                        <StartingPosition>217</StartingPosition>
                                        <EndingPosition>225</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P21171.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>169963</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Peptide conjugate</ComplexType>
                                    <PeptideModifications/>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Stimulation of IFN-g release by peptide specific CD8 cells is seen when APCs are infected with Yersinia enterocolitica bearing plasmid encoding for recombinant fusion protein between p60 214-273 fragment and Type III secretion protein YopE fragment shown to mediate secretion and translocation (N-ter 138 aa), but not with YopE fragment with secretion but not translocation activity (N-ter 18 aa). The co-localized expression of YopE specific chaperone SycE greatly enhances the translocation and presentation of recombinant protein. This delivery system is able to accommodate large protein fragments without compromising its epitope presentation capability.  IFN-g in the supernatant was assayed by ELISA after APCs were infected with Y. enterocolitica bearing the recombinant plasmid,  fixed,  and peptide specific CD8 cell lines were added. .</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p60 449-457</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IYVGNGQMI</LinearSequence>
                        <StartingPosition>449</StartingPosition>
                        <EndingPosition>457</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P21171.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>169963</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Received from author.</LocationOfData>
                <EpitopeId>29715</EpitopeId>
                <ReferenceStartingPosition>449</ReferenceStartingPosition>
                <ReferenceEndingPosition>457</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Kd restricted epitope. Also known as Protein p60 precursor and  Invasion-associated protein.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <TCellId>9530</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>169963</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1st dose of 5x10&lt;sup&gt;3&lt;/sup&gt; CFU, 2nd dose of 10^6 CFU 2 wks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>P815-Mast cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IYVGNGQMI</LinearSequence>
                                            <StartingPosition>449</StartingPosition>
                                            <EndingPosition>457</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P21171.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>169963</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Peptide specific T cell line was established by incubation with epitopic peptide  and restimulated every 3-4 wks with P815/B7 accessory cells.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10000055</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>p60 445-479</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IYVGNGQMI</LinearSequence>
                                        <StartingPosition>449</StartingPosition>
                                        <EndingPosition>457</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P21171.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>169963</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Peptide conjugate</ComplexType>
                                    <PeptideModifications/>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Stimulation of IFN-g release by peptide specific CD8 cells is seen when APCs are infected with Yersinia enterocolitica bearing plasmid encoding for recombinant fusion protein between p60 445-479 fragment and Type III secretion protein YopE fragment shown  to mediate secretion and translocation, but not with YopE fragment with secretion but not translocation activity (N-ter 18 aa). The co-localized expression of YopE specific chaperone SycE greatly enhances the translocation and presentation of recombinant protein. This delivery system is able to accommodate large protein fragments without compromising its epitope presentation capability.  IFN-g in the supernatant was assayed by ELISA after APCs were infected with Y. enterocolitica bearing the recombinant plasmid,  fixed,  and peptide specific CD8 cell lines were added. .</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

